Jonathan Dye
Overview
Explore the profile of Jonathan Dye including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
43
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Buckley M, Arainga M, Maiorino L, Pires I, Kim B, Michaels K, et al.
Mol Ther
. 2025 Jan;
33(3):1105-1117.
PMID: 39797396
mRNA delivered using lipid nanoparticles (LNPs) has become an important subunit vaccine modality, but mechanisms of action for mRNA vaccines remain incompletely understood. Here, we synthesized a metal chelator-lipid conjugate...
2.
Roerden M, Castro A, Cui Y, Harake N, Kim B, Dye J, et al.
J Immunother Cancer
. 2024 Nov;
12(11).
PMID: 39521615
Background: Intratumoral heterogeneity (ITH) and subclonal antigen expression blunt antitumor immunity and are associated with poor responses to immune-checkpoint blockade immunotherapy (ICB) in patients with cancer. The underlying mechanisms however...
3.
Buckley M, Arainga M, Maiorino L, Pires I, Kim B, Michaels K, et al.
bioRxiv
. 2024 Jul;
PMID: 38979236
mRNA delivered using lipid nanoparticles (LNPs) has become an important subunit vaccine modality, but mechanisms of action for mRNA vaccines remain incompletely understood. Here, we synthesized a metal chelator-lipid conjugate...
4.
Pires I, Ni K, Melo M, Li N, Ben-Akiva E, Maiorino L, et al.
Chem Eng J
. 2024 May;
464.
PMID: 38737525
Immune stimulating complexes (ISCOMs) are safe and effective saponin-based adjuvants formed by the self-assembly of saponin, cholesterol, and phospholipids in water to form cage-like 30-40 nm diameter particles. Inclusion of...
5.
Ma L, Hostetler A, Morgan D, Maiorino L, Sulkaj I, Whittaker C, et al.
Cell
. 2023 Jul;
186(15):3148-3165.e20.
PMID: 37413990
Chimeric antigen receptor (CAR) T cell therapy effectively treats human cancer, but the loss of the antigen recognized by the CAR poses a major obstacle. We found that in vivo...
6.
Wade E, Dye J, Mead R, Mataric M
IEEE Int Conf Rehabil Robot
. 2012 Jan;
2011:5975358.
PMID: 22275562
We present an application of a socially assistive robotics (SAR) system in a therapeutic setting. We examine the amount of interaction elicited by the robot in a therapeutic setting with...